Bioanalytical Testing Services Market Size to Reach USD 4.33 Billion in 2028 | Revenue, Industry Statistics, Share, Analysis and Global Research Report by Emergen Research Print E-mail
Tuesday, 18 May 2021 16:00

Vancouver, British Columbia, May 18, 2021 (GLOBE NEWSWIRE)

Vancouver, British Columbia, May 18, 2021 (GLOBE NEWSWIRE) -- The global bioanalytical testing services market size is expected to reach USD 4.33 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research. Factors such as rising focus on analytical testing of biosimilars and biologics, increasing research and development expenditure in biopharmaceutical and pharmaceutical sectors, and growing adoption of Quality by Design (QbD) approach are boosting revenue growth of the global bioanalytical testing services market. Bioanalytical testing services involve quantitative measurement of drugs and their metabolites in biological fluids such as blood, serum, urine, plasma, or tissue extracts. Bioanalytical program includes sample preparation, development of bioanalytical method, validation, ensuring quantitative outcome that demonstrate accuracy, selectivity, precision, and stability.

Claim Your FREE Sample Copy with Table of [email protected]

Liquid chromatography–mass spectrometry (LC–MS), gas chromatography–mass spectrometry (GC–MS), capillary electrophoresis–mass spectrometry (CE–MS), high performance liquid chromatography (HPLC) are some of the widely used techniques in bioanalytical testing services. Major prevalence of cancer, rising demand for generic drug development, increasing investment in drug development, and growing number of biotechnology companies are expected to drive revenue growth of the market going ahead.

.Some Key Findings in the Report:

  • In November 2019, BioAgilytix acquired Cambridge Biomedical. This acquisition helped BioAgilytix to expand its business globally, and also strengthens its ability to support every phase of biologics development.
  • Oncology segment accounted for largest revenue share in the global market in 2020. Rising number of clinical trials conducted for oncology and major prevalence of cancer are major factors driving revenue growth of this segment.
  • North America accounted for a 32.3% revenue share contribution in the global market in 2020. Robust presence of key market players, developments in pharmaceutical biotechnology industries, and ongoing clinical trials are some major factors driving revenue growth of the market in this region.
  • Key players operating in the market are Charles River Laboratories, Medpace, Inc., Wuxi AppTec, IQVIA, Inc, SGS SA, Laboratory Corporation of America Holdings, Intertek Group plc, PRA Health Sciences, Syneos Health, and Frontage Laboratories, Inc.

Check Our [email protected]

For the purpose of this report, Emergen Research has segmented the global bioanalytical testing services market based on type, application, end-use, and region:

  • Type Outlook (Revenue, USD Billion; 2018–2028)
  • Cell-based Assays
  • Virology Testing
  • Method Development Optimization and Validation
  • Serology Immunogenicity and Neutralizing Antibodies
  • Pharmacokinetic Testing
  • Biomarker Testing
  • Others
  • Application Outlook (Revenue, USD Billion; 2018–2028)
    • Neurology
    • Oncology
    • Infectious Diseases
    • Cardiology
    • Gastroenterology
    • Other
  • End-Use Outlook (Revenue, USD Billion; 2018–2028)$1$1$1
    • Biopharmaceutical and Pharmaceutical Companies
    • Contract Development and Manufacturing Organizations
    • Contract Research Organizations

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

  • Regional Outlook (Revenue: USD Billion; 2018–2028)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. BENELUX
      5. Italy
      6. Spain
      7. Switzerland
      8. Russia
      9. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. India
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. South Africa
      4. Turkey
      5. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Facebook | LinkedIn | Twitter | Blogs |YouTube | Instagram

Read Full Press [email protected]

Primary Logo

"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!